Promoted Companies
SORT BY:
Chelsea Therapeutics International Ltd. (CHTP)
| Total paid for Promotions this month: | $0 | ||
| E-mails this Month: | 6 | ||
| Estimated Volume Generated: | $0 | ||
| Research Report on CHTP: | Click to see | ||
| * The information presented is based on information for Jan , 2014 | |||
FDA approves CHTP - Heavy Interest Pre-Market Jan 15, 2014 09:17
Dear Profit Reader
PRESS RELEASEJan. 14, 2014, 5:09 p.m. ESTFDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOHCHARLOTTE, N.C., Jan 14, 2014 (GLOBE NEWSWIRE via COMTEX) -- Chelsea Therapeutics International, Ltd. CHTP +156.52% today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC)
...read more
| Promoter: | Wall Street Breakouts | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |
FDA Advisory Panel Recommendation Could Change Its Trading Levels Jan 15, 2014 02:02
FDA Advisory Panel Recommendation Could Change Its Trading Levels
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Chelsea Therapeutics International, Ltd. (CHTP)
Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.
Symptoms
...read more
| Promoter: | pennyomega.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |
FDA Advisory Panel Recommendation Could Change Its Trading Levels Jan 15, 2014 01:31
FDA Advisory Panel Recommendation Could Change Its Trading Levels
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Chelsea Therapeutics International, Ltd. (CHTP)
Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.
Symptoms
...read more
| Promoter: | penny to buck | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |
FDA Advisory Panel Recommendation Could Change Its Trading Levels Jan 15, 2014 01:30
FDA Advisory Panel Recommendation Could Change Its Trading Levels
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Chelsea Therapeutics International, Ltd. (CHTP)
Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.
Symptoms
...read more
| Promoter: | stockbling.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |
FDA Advisory Panel Recommendation Could Change Its Trading Levels Jan 15, 2014 01:26
FDA Advisory Panel Recommendation Could Change Its Trading Levels
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Chelsea Therapeutics International, Ltd. (CHTP)
Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.
Symptoms
...read more
| Promoter: | Crwefinance.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |
FDA Advisory Panel Recommendation Could Change Its Trading Levels Jan 15, 2014 01:23
FDA Advisory Panel Recommendation Could Change Its Trading Levels
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Chelsea Therapeutics International, Ltd. (CHTP)
Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.
Symptoms
...read more
| Promoter: | Double in stocks | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| CHTP | Unknown compensation | UNKNOWN |
| Max Profit: 0.35 % | Gain at close: -23.44 % |